Medicine
Cephalexin 500 mg capsule
Cephalexin 500 mg capsule is a generic prescription medicine for oral use, made by 28 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Cephalexin capsules USP, are supplied as follows: 500 mg Capsules, Green…
Key facts
- Active ingredient (INN)
- Cephalexin
- Brand
- Sold under the generic name
- Strength
- 500 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 100 capsules, 500 capsules, 1000 capsules and 274 more
- Manufacturers
- Ascend LaboratoriesIndiaAurobindo PharmaIndiaLupinIndiaBryant Ranch PrepackA-S Medication SolutionsCronus PharmaTeva PharmaceuticalsAmella PharmaChartwell RXPharma-C28 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Cephalexin capsules USP, are supplied as follows: 500 mg Capsules, Green, Capsule shape, Imprint: 500,LUPIN PACKAGING: 10 in 1 BOTTLE PLASTIC NDC 76420-831-10 (relabeled from NDC: 70518-3857-2) PACKAGING: 30 in 1 BLISTER PACK NDC 76420-831-30 (relabeled from NDC: 70518-3857-1) PACKAGING: 40 in 1 BOTTLE PLASTIC NDC 76420-831-40 (relabeled from NDC: 70518-3857-3) PACKAGING: 42 in 1 BOTTLE PLASTIC…
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01DB01 Cephalexin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 September 1990
- Identifiers
- RxCUI 309114, 309112, 637173 +1DailyMed set ID 945552cb-90e4-41fb-afe2-8ee8785e94da, da97ca40-3b22-432b-a3e9-0902dbef06a9, ee0603a5-0758-4968-89e3-1aa95e9967f2 +37NDC 76420-831, 85766-191, 50090-3427 +37Application ANDA065229, ANDA090836, ANDA065253 +3
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 28 labelers. The register lists 277 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 capsule in 1 bottle | 67877-219-01 | Ascend LaboratoriesIndia | 19 January 2011 |
| 500 capsule in 1 bottle | 67877-219-05 | Ascend LaboratoriesIndia | 19 January 2011 |
| 1000 capsule in 1 bottle | 67877-219-10 | Ascend LaboratoriesIndia | 19 January 2011 |
| 20 capsule in 1 bottle | 67877-219-20 | Ascend LaboratoriesIndia | 19 January 2011 |
| 100 blister pack in 1 carton / 1 capsule in 1 blister pack | 67877-219-38 | Ascend LaboratoriesIndia | 19 January 2011 |
| 50 blister pack in 1 carton / 1 capsule in 1 blister pack | 67877-219-74 | Ascend LaboratoriesIndia | 19 January 2011 |
| 30 blister pack in 1 carton / 1 capsule in 1 blister pack | 67877-219-84 | Ascend LaboratoriesIndia | 19 January 2011 |
| 100 capsule in 1 bottle | 65862-019-01 | Aurobindo PharmaIndia | 16 November 2005 |
| 500 capsule in 1 bottle | 65862-019-05 | Aurobindo PharmaIndia | 16 November 2005 |
| 20 capsule in 1 bottle | 65862-019-20 | Aurobindo PharmaIndia | 16 November 2005 |
| 40 capsule in 1 bottle | 65862-019-40 | Aurobindo PharmaIndia | 16 November 2005 |
| 100 capsule in 1 bottle | 68180-122-01 | LupinIndia | 1 November 2006 |
| 500 capsule in 1 bottle | 68180-122-02 | LupinIndia | 1 November 2006 |
| 100 capsule in 1 bottle | 72287-310-01 | Amella Pharma | 27 June 2018 |
| 40 capsule in 1 bottle | 62135-711-74 | Chartwell RX | 23 February 2023 |
| 100 capsule in 1 bottle | 69043-009-01 | Cronus Pharma | 16 November 2005 |
| 500 capsule in 1 bottle | 69043-009-05 | Cronus Pharma | 16 November 2005 |
| 500 capsule in 1 bottle, plastic | 69778-931-04 | Pharma-C | 11 October 2016 |
| 100 capsule in 1 bottle | 0093-3147-01 | Teva Pharmaceuticals | 30 September 1990 |
| 500 capsule in 1 bottle | 0093-3147-05 | Teva Pharmaceuticals | 30 September 1990 |
| 40 capsule in 1 bottle | 63629-4219-1 | Bryant Ranch Prepack | 20 April 2026 |
| 20 capsule in 1 bottle | 63629-5740-1 | Bryant Ranch Prepack | 3 June 2025 |
| 28 capsule in 1 bottle | 63629-5741-1 | Bryant Ranch Prepack | 3 June 2025 |
| 30 capsule in 1 bottle | 63629-5742-1 | Bryant Ranch Prepack | 3 June 2025 |
| 28 capsule in 1 bottle | 63629-7740-1 | Bryant Ranch Prepack | 2 September 2022 |
| 20 capsule in 1 bottle | 63629-7742-1 | Bryant Ranch Prepack | 19 January 2011 |
| 14 capsule in 1 bottle | 63629-7743-1 | Bryant Ranch Prepack | 2 September 2022 |
| 12 capsule in 1 bottle | 63629-8184-1 | Bryant Ranch Prepack | 17 August 2022 |
| 500 capsule in 1 bottle | 63629-8856-1 | Bryant Ranch Prepack | 19 January 2011 |
| 100 capsule in 1 bottle | 63629-9200-1 | Bryant Ranch Prepack | 19 January 2011 |
| 500 capsule in 1 bottle | 63629-9201-1 | Bryant Ranch Prepack | 19 January 2011 |
| 14 capsule in 1 bottle | 71335-2685-1 | Bryant Ranch Prepack | 17 September 2025 |
| 21 capsule in 1 bottle | 71335-2704-1 | Bryant Ranch Prepack | 26 September 2025 |
| 12 capsule in 1 bottle | 71335-2976-1 | Bryant Ranch Prepack | 6 November 2025 |
| 100 capsule in 1 bottle | 72162-1830-1 | Bryant Ranch Prepack | 8 March 2024 |
| 500 capsule in 1 bottle | 72162-1830-2 | Bryant Ranch Prepack | 8 March 2024 |
| 500 capsule in 1 bottle | 72162-1830-5 | Bryant Ranch Prepack | 8 March 2024 |
| 500 capsule in 1 bottle | 72162-2145-5 | Bryant Ranch Prepack | 7 December 2023 |
| 20 capsule in 1 bottle | 50090-0079-0 | A-S Medication Solutions | 28 November 2014 |
| 28 capsule in 1 bottle | 50090-0079-1 | A-S Medication Solutions | 28 November 2014 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 4 January 1971 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Cephalexin
Clinical summary
Cephalexin is a cephalosporin antibacterial indicated for the treatment of infections when caused by susceptible strains of the designated microorganisms. It is available as capsules, powder for oral suspension and tablets. MedsAcross supplies Cephalexin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CephalexinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cephalexin prescribing information (Ascend Laboratories) · U.S. National Library of Medicine, DailyMed
Need Cephalexin 500 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.